Document Detail


Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy.
MedLine Citation:
PMID:  21213289     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND:: Infliximab (IFX) and adalimumab (ADA) are attractive treatment options in patients with inflammatory bowel disease (IBD) also during pregnancy but there is still limited data on the benefit/risk profile of IFX and ADA during pregnancy. METHODS:: This observational study assessed pregnancy outcomes in 212 women with IBD under antitumor necrosis factor alpha (TNF) treatment at our IBD unit. Pregnancy outcomes in 42 pregnancies with direct exposure to anti-TNF treatment (35 IFX, 7 ADA) were compared with that in 23 pregnancies prior to IBD diagnosis, 78 pregnancies before start of IFX, 53 pregnancies with indirect exposure to IFX, and 56 matched pregnancies in healthy women. RESULTS:: Thirty-two of the 42 pregnancies ended in live births with a median gestational age of 38 weeks (interquartile range [IQR] 37-39). There were seven premature deliveries, six children had low birth weight, and there was one stillbirth. One boy weighed 1640 g delivered at week 33, died at age of 13 days because of necrotizing enterocolitis. A total of eight abortions (one patient wish) occurred in seven women. Trisomy 18 was diagnosed in one fetus of a mother with CD at age 37 under ADA treatment (40 mg weekly) and pregnancy was terminated. Pregnancy outcomes after direct exposure to anti-TNF treatment were not different from those in pregnancies before anti-TNF treatment or with indirect exposure to anti-TNF treatment but outcomes were worse than in pregnancies before IBD diagnosis. CONCLUSIONS:: Direct exposure to anti-TNF treatment during pregnancy was not related to a higher incidence of adverse pregnancy outcomes than IBD overall. (Inflamm Bowel Dis 2011;).
Authors:
Fabian Schnitzler; Herma Fidder; Marc Ferrante; Vera Ballet; Maja Noman; Gert Van Assche; Bernard Spitz; Ilse Hoffman; Kristel Van Steen; Séverine Vermeire; Paul Rutgeerts
Related Documents :
11704199 - Idiopathic osteonecrosis of the hip during pregnancy: outcome in a subsequent gestation.
12832939 - Ethical issues in the management of pregnancies complicated by fetal anomalies.
17849519 - Introduction of an early pregnancy assessment unit: audit on the first 6 months of serv...
16825069 - Gestational sac aspiration: a novel alternative to dilation and evacuation for manageme...
15502629 - Congenital hypofibrinogenemia in pregnancy: report of two cases and review of the liter...
3171379 - Nasal granuloma gravidarum.
20476879 - Vascularization of the placenta and the sub-placental myometrium: feasibility and repro...
17537659 - Mutation analysis a prerequisite for prenatal diagnosis of l-2-hydroxyglutaric aciduria?
6635999 - Maternal characteristics and hypospadias: a case-control study.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-1-6
Journal Detail:
Title:  Inflammatory bowel diseases     Volume:  -     ISSN:  1536-4844     ISO Abbreviation:  -     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-1-7     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9508162     Medline TA:  Inflamm Bowel Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Use of a novel vitamin d bioavailability test demonstrates that vitamin D absorption is decreased in...
Next Document:  Blood-based biomarkers can differentiate ulcerative colitis from crohn's disease and noninflammatory...